Questcor Pharmacueticals (NASDAQ: QCOR) reported Q2 EPS of $1.35, $0.35 better than the analyst estimate of $1.00. Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE